Funding The authors did not receive any funding for this work
Figure 1: Changes in body weight from baseline to the end of treatment at week 26 associated with the trial product estimand, in the randomly assigned treatment groups administered either 0.3 mg of cagrilintide, 0.6 mg of cagrilintide, 1.2 mg of cagrilintide, 2.5 mg of cagrilintide, 4.5 mg of cagrilintide, 3.0 mg of liraglutide, or a placebo
Enhance overall gut function, thereby improving nutrient absorption and reducing symptoms associated with gluten sensitivity and autoimmune conditions
Scientists conducting research must ensure their experimental protocols comply with research-use regulations
Once again, I remembered methylene blue
Elevated cAMP leads to activation of protein kinase A, which regulates key enzymes involved in triglyceride breakdown